Toray Industries, Inc. has developed a technology to control the pore size of polymethyl methacrylate (PMMA) porous fibers in a range from a few nanometers to approximately 1,000 nanometers. This advancement allows for the selective adsorption of disease-causing substances, such as autoantibodies and lipoproteins, which are linked to intractable diseases like autoimmune disorders, cancer, and neurodegenerative diseases. Toray aims to commercialize this technology for both therapeutic blood purification and biopharmaceutical manufacturing applications.
FACT BOX
- Source: PR Times
- Category: research